Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens

Clin Microbiol Infect. 2000 Dec;6(12):653-6. doi: 10.1046/j.1469-0691.2000.00159.x.

Abstract

Objective: The epidemiology of Group A Streptococcus (GAS) in Greece is not known. We have therefore conducted this prospective study to investigate the isolation rate of GAS from pediatric specimens, determine T-serotype frequency and examine the susceptibility of GAS to penicillin, erythromycin and clindamycin.

Methods: Over a 3-year study-period (1993-95) 11 597 clinical specimens obtained from sick children were inoculated on appropriate culture media. The isolation and identification of GAS strains were assessed by conventional methods. T-typing was performed by slide agglutination. Serum opacity factor (OF) was detected by microwell

Method: The susceptibility of the strains was tested by the Kirby Bauer method.

Results: GAS were isolated from 1125 out of 11 597 (9.7%) clinical specimens, mostly from throat samples (15.6%). T-serotyping was performed in 652 GAS strains. A significant difference of the incidence of T-serotypes was observed within the 3 years studied (chi2 = 70.3, DF = 18, P < 0.001). The most dominant isolates were T-1 (25%), T-4 (20%) and T-12 (16%) during 1993, 1994 and 1995, respectively. Non-typeable (NT) strains were 4%. OF and hyaluronic acid were produced from 49.8% and 3% of the strains, respectively. All isolated strains were susceptible to penicillin and clindamycin. Resistance to erythromycin was 5.0-8.7% over the 3-year study period.

Conclusions: There was a wide distribution of GAS T-serotypes in Athens and a significant change in their annual predominance. All strains were susceptible to penicillin and clindamycin, but a low level of erythromycin resistance was observed.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Clindamycin / therapeutic use
  • Drug Resistance, Microbial
  • Erythromycin / therapeutic use
  • Greece / epidemiology
  • Humans
  • Infant
  • Microbial Sensitivity Tests
  • Penicillins / therapeutic use
  • Prospective Studies
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / epidemiology
  • Streptococcal Infections / microbiology*
  • Streptococcus pyogenes / classification
  • Streptococcus pyogenes / drug effects*
  • Streptococcus pyogenes / isolation & purification*

Substances

  • Anti-Bacterial Agents
  • Penicillins
  • Clindamycin
  • Erythromycin